Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01861665 · ClinicalTrials.gov registry record · NA
Marcaine Use in Laparoscopic Gynecological Surgery
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT01861665 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 27 participants.
The verdict
NCT01861665, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this trial is to compare incisional pain in patients receiving pre-incisional versus post operative Marcaine injection.
Interventions
- DRUG Marcaine- 0.25%
- DRUG Marcaine 0.25%.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2010-06 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01861665
The ClinicalTrials.gov registry entry for NCT01861665 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Marcaine- 0.25% is the first listed.
NCT01861665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01861665 about?
NCT01861665 is a clinical study titled "Marcaine Use in Laparoscopic Gynecological Surgery". The purpose of this trial is to compare incisional pain in patients receiving pre-incisional versus post operative Marcaine injection.
What is the current status of trial NCT01861665?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2010-06. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01861665?
The interventions under investigation include: Marcaine- 0.25% (DRUG), Marcaine 0.25%. (DRUG).
Who is sponsoring clinical trial NCT01861665?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.